EBMT-EHA 6th European CAR T-Cell Meeting 2024: Advancing Treatments and New Frontiers
In recent years, chimeric antigen receptor (CAR) T-cell therapies have revolutionized hemato-oncology. They have greatly improved outcomes of patients with B-cell malignancies and, with some challenges still existing, their potential continues to be explored in novel modalities and indications. The...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2024-06-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/HBT.OH.2024.20.148 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|